Comparative Analysis of MGAP and GAP Trauma Scores in Predicting Outcomes for Multiple Trauma Pat… (NCT06732791) | Clinical Trial Compass
RecruitingNot Applicable
Comparative Analysis of MGAP and GAP Trauma Scores in Predicting Outcomes for Multiple Trauma Patients
Iraq522 participantsStarted 2025-01-20
Plain-language summary
The goal of this prospective cohort study is to compare the predictive accuracy of the MGAP and GAP trauma scores in determining the prognosis of multiple trauma patients admitted to the emergency department at Al-Kadhimiya Teaching Hospital, Iraq.
The main questions it aims to answer are:
Does the MGAP score provide a more accurate prediction of outcomes compared to the GAP score? Are there specific subgroups of trauma patients where one score demonstrates superior predictive utility over the other?
Participants will:
Be assessed using both the MGAP and GAP scores upon admission to the emergency department.
Have their clinical outcomes, including mortality, length of stay, and need for surgery, tracked throughout their hospital stay.
Who can participate
Age range
16 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Aged 16 years or older.
* Patients presenting with multiple trauma (Multiple trauma is defined as injuries involving two or more body regions or organ systems that might need coordinated multidisciplinary management).
* Patients presenting to the emergency department within 6 hours of sustaining trauma.
* Patients or their legal representatives must provide informed consent for participation in the study.
Exclusion Criteria:
* Transfers from other facilities with interventions that may affect GAP or MGAP reliability.
* Pregnant women.
* Burn injuries represent the primary mechanism of trauma.
* Incomplete records or failure of follow-up
* Patients who are deceased upon arrival at the emergency department.
* Patient discharge against medical advice.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
In hospital mortality
Timeframe: In-Hospital Phase (average of 7-10 days through discharge)